Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
This hotel REIT (real estate investment trust) presently has a Zacks #2 Rank (Buy).
Strong First Quarter
On May 1, 2012, Chesapeake reported strong first quarter results with a 109.6% year-over-year growth in total revenue to $50.3 million.
Adjusted FFO/share jumped 171.4% year-over-year to 19 cents, exceeding the Zacks Consensus Estimate by 6 cents. Adjusted EBITDA surged by a phenomenal 269.2% year-over-year to $9.6 million, while pro forma RevPAR (revenue per available room) increased 12.2% to $123.22, exceeding the U.S. industry-wide RevPAR growth by a broad margin of 430 basis points.
With focused asset management efforts and accretive acquisitions, Chesapeake increased its dividend payout for the first quarter by 10% to 22 cents per share, or 88 cents on an annualized basis.
Fiscal Outlook Raised
Chesapeake raised its 2012 adjusted FFO/share guidance to $1.60 $1.69 from the earlier range of $1.55 $1.64. Adjusted hotel EBITDA is presently expected in the range of $83.2 million $86.7 million compared with the earlier projection of $82.3 million $85.6 million. Pro forma RevPAR for 2012 is expected to grow in the range of 7.5% - 9.0% compared with the earlier expectation of 6.5% - 8.5%.
Surge in Earnings Estimate Revisions
Over the past 60 days, the Zacks Consensus Estimate for 2012 increased 3.1% to $1.66, while the outlook for 2013 advanced 5.2% to $2.03. The 2012 earnings estimate is on the higher end of the companys guidance range.
Reasonable Valuation
Chesapeakes valuation looks reasonable on a price-to-earnings (P/E) and price-to-book (P/B) basis. Shares of Chesapeake are currently trading at a forward P/E of 10.65x, a 5.2% discount to the peer group average of 11.24x. On a P/B basis, Chesapeake is currently trading at 1.11x versus 1.19x for the peer group. Shares also look pretty impressive with a ROE of 1.9%, which is better than the peer group average of 0.9%.
Chart Resonates Growth Potential
Since December 20, 2011, Chesapeake shares have consistently fared relatively better than the simple moving average for 200 days or SMA (200). The year-to-date return for the stock is noteworthy at 14.55% compared to a S&P tally of 6.92%.
Chesapeake owns luxury and upper-upscale hotels in some of the most desirable locations in the U.S. such as Boston, San Francisco, and Seattle. The company specifically focuses on owning and acquiring upscale hotels at prices well below replacement costs, with attractive return on investments and significant upside potential. Chesapeake currently owns 12 hotels with an aggregate of 3,516 rooms in 6 states in the U.S. and the District of Columbia. The company presently has a market cap of $568.97 million.
Get the full Snapshot Report on CHSP - FREE